Cargando…

Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid

BACKGROUND: Multiple skin conditions have been associated with alterations in the diversity and composition of the skin microbiome, including dry skin and atopic dermatitis. In these conditions, a number of commensal skin bacteria have been implicated in supporting a healthy skin barrier, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu-Walsh, Fang, Tierney, Neena K, Hauschild, James, Rush, Allison K, Masucci, John, Leo, Gregory C, Capone, Kimberly A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826061/
https://www.ncbi.nlm.nih.gov/pubmed/33500646
http://dx.doi.org/10.2147/CCID.S253386
_version_ 1783640452329635840
author Liu-Walsh, Fang
Tierney, Neena K
Hauschild, James
Rush, Allison K
Masucci, John
Leo, Gregory C
Capone, Kimberly A
author_facet Liu-Walsh, Fang
Tierney, Neena K
Hauschild, James
Rush, Allison K
Masucci, John
Leo, Gregory C
Capone, Kimberly A
author_sort Liu-Walsh, Fang
collection PubMed
description BACKGROUND: Multiple skin conditions have been associated with alterations in the diversity and composition of the skin microbiome, including dry skin and atopic dermatitis. In these conditions, a number of commensal skin bacteria have been implicated in supporting a healthy skin barrier, including Staphylococcus epidermidis. Recent clinical studies in patients with mild-to-moderate atopic dermatitis and dry/itchy skin have shown significantly improved skin barrier function and microbial diversity upon treatment with moisturizers containing 1% colloidal oat. We hypothesized that direct use of colloidal oat by skin microbes contributes to these therapeutic benefits. METHODS: Skin bacterial growth was assessed using the BacT/ALERT system. Staphylococcus aureus and S. epidermidis growth rates and metabolism were compared in an in vitro competition assay. The effect of a 1% colloidal oat–containing moisturizer on lactic acid content of the stratum corneum was clinically assessed in subjects with moderate-to-severe dry skin. S. epidermidis gene expression was evaluated by next-generation mRNA sequencing. Short-chain fatty acids were quantified in bacterial culture supernatants. RESULTS: In vitro, colloidal oat increased the growth rate of S. epidermidis vs S. aureus, as well as the metabolism of S. epidermidis. Colloidal oat also significantly increased lactic acid concentrations in supernatants of both strains and decreased pH, consistent with clinical findings that 6-week use of a 1% colloidal oat–containing lotion significantly increased lactic acid on dry skin. Further analyses suggest that colloidal oat alters the gene expression profile of S. epidermidis. CONCLUSION: Colloidal oat directly affects the growth, metabolism, lactic acid production, and gene expression of skin commensal bacteria, as shown via in vitro studies. The increased production of lactic acid reflects clinical observations with colloidal oat–containing skin moisturizers. Our findings suggest a new mechanism for colloidal oat as a skin prebiotic, which may contribute to improvements in skin and microbiome diversity in various skin conditions, including dry/itchy skin and atopic dermatitis.
format Online
Article
Text
id pubmed-7826061
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78260612021-01-25 Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid Liu-Walsh, Fang Tierney, Neena K Hauschild, James Rush, Allison K Masucci, John Leo, Gregory C Capone, Kimberly A Clin Cosmet Investig Dermatol Original Research BACKGROUND: Multiple skin conditions have been associated with alterations in the diversity and composition of the skin microbiome, including dry skin and atopic dermatitis. In these conditions, a number of commensal skin bacteria have been implicated in supporting a healthy skin barrier, including Staphylococcus epidermidis. Recent clinical studies in patients with mild-to-moderate atopic dermatitis and dry/itchy skin have shown significantly improved skin barrier function and microbial diversity upon treatment with moisturizers containing 1% colloidal oat. We hypothesized that direct use of colloidal oat by skin microbes contributes to these therapeutic benefits. METHODS: Skin bacterial growth was assessed using the BacT/ALERT system. Staphylococcus aureus and S. epidermidis growth rates and metabolism were compared in an in vitro competition assay. The effect of a 1% colloidal oat–containing moisturizer on lactic acid content of the stratum corneum was clinically assessed in subjects with moderate-to-severe dry skin. S. epidermidis gene expression was evaluated by next-generation mRNA sequencing. Short-chain fatty acids were quantified in bacterial culture supernatants. RESULTS: In vitro, colloidal oat increased the growth rate of S. epidermidis vs S. aureus, as well as the metabolism of S. epidermidis. Colloidal oat also significantly increased lactic acid concentrations in supernatants of both strains and decreased pH, consistent with clinical findings that 6-week use of a 1% colloidal oat–containing lotion significantly increased lactic acid on dry skin. Further analyses suggest that colloidal oat alters the gene expression profile of S. epidermidis. CONCLUSION: Colloidal oat directly affects the growth, metabolism, lactic acid production, and gene expression of skin commensal bacteria, as shown via in vitro studies. The increased production of lactic acid reflects clinical observations with colloidal oat–containing skin moisturizers. Our findings suggest a new mechanism for colloidal oat as a skin prebiotic, which may contribute to improvements in skin and microbiome diversity in various skin conditions, including dry/itchy skin and atopic dermatitis. Dove 2021-01-19 /pmc/articles/PMC7826061/ /pubmed/33500646 http://dx.doi.org/10.2147/CCID.S253386 Text en © 2021 Liu-Walsh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu-Walsh, Fang
Tierney, Neena K
Hauschild, James
Rush, Allison K
Masucci, John
Leo, Gregory C
Capone, Kimberly A
Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title_full Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title_fullStr Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title_full_unstemmed Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title_short Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid
title_sort prebiotic colloidal oat supports the growth of cutaneous commensal bacteria including s. epidermidis and enhances the production of lactic acid
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826061/
https://www.ncbi.nlm.nih.gov/pubmed/33500646
http://dx.doi.org/10.2147/CCID.S253386
work_keys_str_mv AT liuwalshfang prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT tierneyneenak prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT hauschildjames prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT rushallisonk prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT masuccijohn prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT leogregoryc prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid
AT caponekimberlya prebioticcolloidaloatsupportsthegrowthofcutaneouscommensalbacteriaincludingsepidermidisandenhancestheproductionoflacticacid